Jennison Associates LLC Grows Position in Select Medical Holdings Co. (NYSE:SEM)

Jennison Associates LLC raised its stake in Select Medical Holdings Co. (NYSE:SEM - Free Report) by 542.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 115,185 shares of the health services provider's stock after acquiring an additional 97,264 shares during the period. Jennison Associates LLC owned 0.09% of Select Medical worth $2,171,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. GAMMA Investing LLC grew its stake in Select Medical by 16.6% during the 3rd quarter. GAMMA Investing LLC now owns 2,313 shares of the health services provider's stock worth $81,000 after buying an additional 330 shares during the last quarter. KBC Group NV grew its position in shares of Select Medical by 4.5% during the third quarter. KBC Group NV now owns 13,050 shares of the health services provider's stock worth $455,000 after acquiring an additional 563 shares during the last quarter. Swiss National Bank increased its holdings in shares of Select Medical by 0.4% in the 3rd quarter. Swiss National Bank now owns 215,900 shares of the health services provider's stock valued at $7,528,000 after acquiring an additional 800 shares during the period. Quarry LP purchased a new stake in Select Medical in the 3rd quarter valued at $30,000. Finally, Sippican Capital Advisors grew its position in Select Medical by 7.3% during the 4th quarter. Sippican Capital Advisors now owns 13,354 shares of the health services provider's stock worth $252,000 after purchasing an additional 912 shares during the last quarter. Institutional investors and hedge funds own 89.48% of the company's stock.

Select Medical Stock Performance

Shares of SEM stock traded down $0.08 during trading hours on Monday, reaching $18.75. 615,941 shares of the company's stock were exchanged, compared to its average volume of 814,093. The company has a debt-to-equity ratio of 1.37, a current ratio of 1.13 and a quick ratio of 1.13. Select Medical Holdings Co. has a 1 year low of $18.02 and a 1 year high of $40.98. The company has a market cap of $2.43 billion, a P/E ratio of 8.76, a price-to-earnings-growth ratio of 0.65 and a beta of 1.45. The company's 50 day moving average is $19.37 and its two-hundred day moving average is $29.18.

Insiders Place Their Bets

In other news, VP Robert G. Breighner, Jr. sold 4,989 shares of Select Medical stock in a transaction that occurred on Wednesday, December 4th. The shares were sold at an average price of $19.95, for a total transaction of $99,530.55. Following the completion of the sale, the vice president now directly owns 30,356 shares in the company, valued at approximately $605,602.20. This trade represents a 14.12 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Marilyn B. Tavenner sold 32,000 shares of the company's stock in a transaction that occurred on Tuesday, November 26th. The stock was sold at an average price of $21.09, for a total value of $674,880.00. Following the completion of the sale, the director now owns 22,000 shares in the company, valued at approximately $463,980. This represents a 59.26 % decrease in their position. The disclosure for this sale can be found here. 19.14% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of equities research analysts have recently commented on the stock. Benchmark cut shares of Select Medical from a "buy" rating to a "hold" rating in a report on Monday, November 25th. Royal Bank of Canada increased their price objective on Select Medical from $40.00 to $47.00 and gave the stock an "outperform" rating in a research report on Monday, November 4th. StockNews.com raised Select Medical from a "hold" rating to a "buy" rating in a report on Monday, January 27th. Finally, UBS Group decreased their price target on Select Medical from $40.00 to $21.00 and set a "neutral" rating for the company in a report on Friday, January 3rd. Two equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $39.50.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.